Antitumor Activity Of A 5-Hydroxy-1h-Pyrrol-2-(5h)-One-Based Synthetic Small Molecule In Vitro And In Vivo

yunyun geng,xiaojian wang,luo yang,haili sun,yongqiang wang,yue zhao,ruiping she,meixiang wang,dexian wang,jun tang
DOI: https://doi.org/10.1371/journal.pone.0128928
IF: 3.7
2015-01-01
PLoS ONE
Abstract:Alternative chemo-reagents are in great demand because chemotherapy resistance is one of the major challenges in current cancer treatment. 5-hydoxy-1H-pyrrol-2-(5H)-one is an important N-heterocyclic scaffold that is present in natural products and medicinal chemistry. However, its antitumor activity has not been systematically explored. In this study, we screened a panel of 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives and identified compound 1d as possessing strong anti-proliferative activity in multiple cancer cell lines. Cell cycle analysis revealed that 1d can induce S-phase cell cycle arrest and that HCT116 was sensitive to 1d-induced apoptosis. Further analysis indicated that 1d preferentially induced DNA damage and p53 activation in HCT116 cells and that 1d-induced apoptosis is partly dependent on p53. Furthermore, we showed that 1d significantly suppressed tumor growth in xenograft tumor models in vivo. Taken together, our results suggest that 5-hydoxy-1H-pyrrol-2-(5H)-one derivatives bear potential antitumor activity and that 1d is an effective agent for cancer treatment.
What problem does this paper attempt to address?